# A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction

> **NCT02199678** · PHASE2 · COMPLETED · sponsor: **Lotus Clinical Research, LLC** · enrollment: 120 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Placebo
- **DRUG:** ketamine 25 mg
- **DRUG:** ketamine 35 mg
- **DRUG:** ketamine 50 mg

## Key facts

- **NCT ID:** NCT02199678
- **Lead sponsor:** Lotus Clinical Research, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2014-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02199678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02199678, "A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02199678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*